Cargando…

A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy

INTRODUCTION: The aim of this study was to compare progression-free survival (PFS) and overall survival (OS) between metachronous and synchronous metastatic renal cell carcinomas treated with VEGF-targeted therapy. METHODS: Between 2005 and 2014, 93 (78.8%) intermediate- and 25 (21.2%) poor-Heng-ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sung Han, Suh, Yoon Seok, Lee, Dong-Eun, Park, Boram, Joo, Jungnam, Joung, Jae Young, Seo, Ho Kyung, Lee, Kang Hyun, Chung, Jinsoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706824/ https://www.ncbi.nlm.nih.gov/pubmed/29212178 http://dx.doi.org/10.18632/oncotarget.20674

Ejemplares similares

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis
por: Kim, Sung Han, et al.
Publicado: (2019)

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy
por: Kim, Sung Han, et al.
Publicado: (2017)

Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease
por: Potthoff, Anna-Laura, et al.
Publicado: (2023)

Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers
por: Lee, Janghee, et al.
Publicado: (2015)

Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy
por: Kim, Sung Han, et al.
Publicado: (2019)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
por: Park, Seongyeol, et al.
Publicado: (2016)

Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer
por: Reboux, Noémi, et al.
Publicado: (2022)

Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study
por: Kim, Sung Han, et al.
Publicado: (2020)

Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
por: Kim, Sung Han, et al.
Publicado: (2017)

A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching
por: Kim, Sung Han, et al.
Publicado: (2018)

Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer
por: Zhang, Li, et al.
Publicado: (2016)

Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer
por: Ding, Shuning, et al.
Publicado: (2021)

Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction
por: Kim, Sung Han, et al.
Publicado: (2017)

Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
por: Ergun, Yakup, et al.
Publicado: (2020)

PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma
por: Yuile, Alexander, et al.
Publicado: (2023)

Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival
por: Sayagués, José María, et al.
Publicado: (2023)

The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma
por: Pape, Marieke, et al.
Publicado: (2022)

Hedgehog Related Protein Expression in Breast Cancer: Gli-2 Is Associated with Poor Overall Survival
por: Im, Soyoung, et al.
Publicado: (2013)

Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis
por: Li, Yuqiang, et al.
Publicado: (2020)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
por: Kim, Sung Han, et al.
Publicado: (2019)

Role of Metastasectomy on Overall Survival of Patients with Metastatic Gastric Cancer
por: Yang, Seung Wook, et al.
Publicado: (2013)

Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases
por: Liu, Jin-Hwang, et al.
Publicado: (2010)

The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry
por: Kim, Sung Han, et al.
Publicado: (2017)

Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups
por: Gok Durnali, Ayse, et al.
Publicado: (2016)

Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
por: Suh, Byoung Jo
Publicado: (2016)

Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
por: Kim, Kyu-pyo, et al.
Publicado: (2017)

Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence
por: Pierce, Daniel P, et al.
Publicado: (2021)

Analysis of Changes in the Total Lymphocyte and Eosinophil Count during Immunotherapy for Metastatic Renal Cell Carcinoma: Correlation with Response and Survival
por: Jeong, In Gab, et al.
Publicado: (2007)

Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
por: Goldstein, David, et al.
Publicado: (2020)

Identification of Significant Prognostic Tissue Markers Associated with Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Radical Nephroureterectomy: A Retrospective Immunohistochemical Analysis Using Tissue Microarray
por: Kim, Sung Han, et al.
Publicado: (2020)

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update
por: Choueiri, Toni K., et al.
Publicado: (2018)

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy
por: Kim, Sung Han, et al.
Publicado: (2016)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

The different clonal origins of metachronous and synchronous metastases
por: Gofrit, Ofer N., et al.
Publicado: (2023)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
por: Kim, Jung Kwon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o6og5iqr2o2g2ohi58svvf6pai